Search
Ardelyx Inc
ARDXAdd to Watchlist
5.175USD
+0.015+0.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.28BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Ardelyx Inc is 9.27, ranking 6 out of 387 in the Biotechnology & Medical Research industry. The average price target is 11.00, with a high of 16.00 and a low of 8.00.
Analyst Rating
Based on
12
analysts
Strong Buy
Current Rating
16.064
Target Price
+207.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Ardelyx Inc
ARDX
12
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Ardelyx Inc's expected revenue for the next quarter?
Ardelyx Inc's expected revenue is 126.77M.
What is Ardelyx Inc's price target?
Analysts forecast that Ardelyx Inc's price target is USD 11.00, with the highest forecast at USD 16.00 and the lowest forecast at USD 8.00.
How have Ardelyx IncARDX's recent earnings per share performed?
The market expectation was USD -0.15, while Ardelyx IncARDX's earnings per share (EPS) for the previous quarter was USD -0.00. EPS for the next quarter is expected at USD -0.04.
What is the analyst rating for Ardelyx Inc?
Based on the ratings of Ardelyx Inc's stock from 12 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.